Molecular mechanisms for the regulation of Nrf2-mediated cell proliferation in non-small-cell lung cancers (Q39411432)

11 September 2017

Molecular mechanisms for the regulation of Nrf2-mediated cell proliferation in non-small-cell lung cancers (English)

1 reference

11 September 2017

T Yamadori

1

1 reference

11 September 2017

Y Ishii

2

1 reference

11 September 2017

S Homma

3

1 reference

11 September 2017

Y Morishima

4

1 reference

11 September 2017

K Kurishima

5

1 reference

11 September 2017

K Itoh

6

1 reference

11 September 2017

M Yamamoto

7

1 reference

11 September 2017

Y Minami

8

1 reference

11 September 2017

M Noguchi

9

1 reference

11 September 2017

N Hizawa

10

1 reference

11 September 2017

language of work or name

English

0 references

publication date

16 January 2012

1 reference

11 September 2017

1 reference

11 September 2017

31

1 reference

11 September 2017

4768-4777

1 reference

11 September 2017

45

1 reference

https://scigraph.springernature.com/pub.10.1038/onc.2011.628

11 September 2017

0 references

cites work

Annual report to the nation on the status of cancer, 1975-2004, featuring cancer in American Indians and Alaska Natives

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.628

Mechanistic studies of the Nrf2-Keap1 signaling pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.628

Loss of Keap1 function activates Nrf2 and provides advantages for lung cancer cell growth.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.628

Nrf2 enhances cell proliferation and resistance to anticancer drugs in human lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.628

RNAi-mediated silencing of nuclear factor erythroid-2-related factor 2 gene expression in non-small cell lung cancer inhibits tumor growth and increases efficacy of chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.628

Oxidative stress sensor Keap1 functions as an adaptor for Cul3-based E3 ligase to regulate proteasomal degradation of Nrf2

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.628

Keap1 is a redox-regulated substrate adaptor protein for a Cul3-dependent ubiquitin ligase complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.628

Nrf2 and Keap1 abnormalities in non-small cell lung carcinoma and association with clinicopathologic features

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.628

Up-regulation of Nrf2-mediated heme oxygenase-1 expression by eckol, a phlorotannin compound, through activation of Erk and PI3K/Akt

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.628

The epidermal growth factor receptor pathway: a model for targeted therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.628

Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.628

EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.628

Differential constitutive activation of the epidermal growth factor receptor in non-small cell lung cancer cells bearing EGFR gene mutation and amplification

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.628

Molecular mechanism activating Nrf2-Keap1 pathway in regulation of adaptive response to electrophiles

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.628

Resveratrol induces glutathione synthesis by activation of Nrf2 and protects against cigarette smoke-mediated oxidative stress in human lung epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.628

Role of Nrf2 in host defense against influenza virus in cigarette smoke-exposed mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.628

Gefitinib or chemotherapy for non-small-cell lung cancer with mutated EGFR

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.628

Exon 19 deletion mutations of epidermal growth factor receptor are associated with prolonged survival in non-small cell lung cancer patients treated with gefitinib or erlotinib

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.628

Clinical course of patients with non-small cell lung cancer and epidermal growth factor receptor exon 19 and exon 21 mutations treated with gefitinib or erlotinib

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.628

KRAS mutation is an important predictor of resistance to therapy with epidermal growth factor receptor tyrosine kinase inhibitors in non-small-cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.628

Acquired resistance to epidermal growth factor receptor tyrosine kinase inhibitors in non-small-cell lung cancers dependent on the epidermal growth factor receptor pathway.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.628

Acquired resistance of lung adenocarcinoma to EGFR-tyrosine kinase inhibitors gefitinib and erlotinib

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.628

EGFR mutation and resistance of non-small-cell lung cancer to gefitinib

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.628

Frequent epigenetics inactivation of KEAP1 gene in non-small cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.628

Detection and quantitation of mutant K-ras codon 12 restriction fragments by capillary electrophoresis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.628

Enhanced cytotoxicity induced by gefitinib and specific inhibitors of the Ras or phosphatidyl inositol-3 kinase pathways in non-small cell lung cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.628

Molecular oncology--perspectives in lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.628

Oncogene-induced Nrf2 transcription promotes ROS detoxification and tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.628

Brusatol enhances the efficacy of chemotherapy by inhibiting the Nrf2-mediated defense mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.628

Genetic ablation of NADPH oxidase enhances susceptibility to cigarette smoke-induced lung inflammation and emphysema in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.628

Preexistence and evolution of imatinib mesylate-resistant clones in chronic myelogenous leukemia detected by a PNA-based PCR clamping technique

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.628

Dimerization and the signal transduction pathway of a small in-frame deletion in the epidermal growth factor receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.628

31 March 2020

Identifiers

DOI

10.1038/ONC.2011.628

1 reference

11 September 2017

1 reference